Purified CD133+ cells, purified from hepatocarcinoma cell lines and from tumor xenografts, survive better than CD133− counterpart to treatment to chemotherapeutic agents (doxorubicin and fluorouracil) [126]. Here, PROM1 is linked to neoplasm.